Cargando…

Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs

The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikonov, O. S., Chernykh, E. S., Garber, M. B., Nikonova, E. Yu.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087576/
https://www.ncbi.nlm.nih.gov/pubmed/29523062
http://dx.doi.org/10.1134/S0006297917130041
_version_ 1783509358308491264
author Nikonov, O. S.
Chernykh, E. S.
Garber, M. B.
Nikonova, E. Yu.
author_facet Nikonov, O. S.
Chernykh, E. S.
Garber, M. B.
Nikonova, E. Yu.
author_sort Nikonov, O. S.
collection PubMed
description The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including humans. Their ubiquitous distribution and high pathogenici- ty motivate active search to counteract enterovirus infections. There are no sufficiently effective drugs targeted against enteroviral diseases, thus treatment is reduced to supportive and symptomatic measures. This makes it extremely urgent to develop drugs that directly affect enteroviruses and hinder their development and spread in infected organisms. In this review, we cover the classification of enteroviruses, mention the most common enterovirus infections and their clinical man- ifestations, and consider the current state of development of anti-enteroviral drugs. One of the most promising targets for such antiviral drugs is the viral Internal Ribosome Entry Site (IRES). The classification of these elements of the viral mRNA translation system is also examined.
format Online
Article
Text
id pubmed-7087576
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Pleiades Publishing
record_format MEDLINE/PubMed
spelling pubmed-70875762020-03-23 Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs Nikonov, O. S. Chernykh, E. S. Garber, M. B. Nikonova, E. Yu. Biochemistry (Mosc) Review The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including humans. Their ubiquitous distribution and high pathogenici- ty motivate active search to counteract enterovirus infections. There are no sufficiently effective drugs targeted against enteroviral diseases, thus treatment is reduced to supportive and symptomatic measures. This makes it extremely urgent to develop drugs that directly affect enteroviruses and hinder their development and spread in infected organisms. In this review, we cover the classification of enteroviruses, mention the most common enterovirus infections and their clinical man- ifestations, and consider the current state of development of anti-enteroviral drugs. One of the most promising targets for such antiviral drugs is the viral Internal Ribosome Entry Site (IRES). The classification of these elements of the viral mRNA translation system is also examined. Pleiades Publishing 2018-01-03 2017 /pmc/articles/PMC7087576/ /pubmed/29523062 http://dx.doi.org/10.1134/S0006297917130041 Text en © Pleiades Publishing, Ltd. 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Nikonov, O. S.
Chernykh, E. S.
Garber, M. B.
Nikonova, E. Yu.
Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
title Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
title_full Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
title_fullStr Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
title_full_unstemmed Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
title_short Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
title_sort enteroviruses: classification, diseases they cause, and approaches to development of antiviral drugs
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087576/
https://www.ncbi.nlm.nih.gov/pubmed/29523062
http://dx.doi.org/10.1134/S0006297917130041
work_keys_str_mv AT nikonovos enterovirusesclassificationdiseasestheycauseandapproachestodevelopmentofantiviraldrugs
AT chernykhes enterovirusesclassificationdiseasestheycauseandapproachestodevelopmentofantiviraldrugs
AT garbermb enterovirusesclassificationdiseasestheycauseandapproachestodevelopmentofantiviraldrugs
AT nikonovaeyu enterovirusesclassificationdiseasestheycauseandapproachestodevelopmentofantiviraldrugs